Procter & Gamble Health Limited (NSE:PGHL) — Stock Price

Rs5966.00 INR
▼ -2.91% today

Procter & Gamble Health Limited (NSE:PGHL) is currently trading at Rs5966.00 INR, down 2.91% today. Over the past 52 weeks, shares have ranged between Rs4778.60 and Rs6918.50. This page tracks Procter & Gamble Health Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market cap of Procter & Gamble Health Limited.

Procter & Gamble Health Limited (PGHL) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Procter & Gamble Health Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Procter & Gamble Health Limited Income Statement — Revenue, Profit & Earnings by Year

Procter & Gamble Health Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023202220212020
Total Revenue Rs12.18 Billion Rs11.51 Billion Rs12.30 Billion Rs11.14 Billion Rs10.09 Billion
Cost of Revenue Rs3.49 Billion Rs3.43 Billion Rs3.83 Billion Rs3.53 Billion Rs3.25 Billion
Gross Profit Rs8.69 Billion Rs8.09 Billion Rs8.46 Billion Rs7.61 Billion Rs6.84 Billion
Research & Development Rs26.10 Million Rs38.60 Million Rs57.10 Million Rs65.50 Million Rs39.30 Million
SG&A Rs1.91 Billion Rs2.16 Billion Rs2.07 Billion Rs1.68 Billion Rs1.55 Billion
Total Operating Expenses Rs2.36 Billion Rs2.72 Billion Rs2.87 Billion Rs2.84 Billion Rs2.47 Billion
Operating Income Rs6.33 Billion Rs5.37 Billion Rs5.59 Billion Rs4.77 Billion Rs4.38 Billion
EBITDA Rs3.62 Billion Rs3.03 Billion Rs3.19 Billion Rs2.65 Billion Rs2.42 Billion
EBIT Rs3.43 Billion Rs2.79 Billion Rs2.96 Billion Rs2.43 Billion Rs2.17 Billion
Interest Expense Rs5.73 Million Rs7.20 Million Rs7.70 Million Rs4.20 Million Rs8.00 Million
Income Before Tax Rs3.34 Billion Rs2.73 Billion Rs3.14 Billion Rs2.53 Billion Rs2.33 Billion
Income Tax Expense Rs832.60 Million Rs723.40 Million Rs847.30 Million Rs608.50 Million Rs564.80 Million
Net Income Rs2.51 Billion Rs2.01 Billion Rs2.29 Billion Rs1.93 Billion Rs1.77 Billion

Procter & Gamble Health Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Procter & Gamble Health Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20242023202220212020
Total Assets Rs7.94 Billion Rs7.94 Billion Rs11.01 Billion Rs8.94 Billion Rs9.86 Billion
Total Current Assets Rs5.26 Billion Rs5.24 Billion Rs7.96 Billion Rs6.14 Billion Rs7.27 Billion
Cash & Equivalents Rs898.10 Million Rs1.50 Billion Rs3.40 Billion Rs3.25 Billion Rs4.18 Billion
Short-term Investments Rs239.80 Million Rs192.30 Million Rs177.30 Million Rs125.90 Million Rs108.40 Million
Net Receivables Rs1.47 Billion Rs1.00 Billion Rs1.16 Billion Rs925.80 Million Rs670.90 Million
Inventory Rs1.09 Billion Rs1.09 Billion Rs1.35 Billion Rs1.15 Billion Rs1.18 Billion
Property, Plant & Equipment Rs1.22 Billion Rs1.32 Billion Rs1.73 Billion Rs1.50 Billion Rs1.40 Billion
Goodwill — — — — —
Total Liabilities Rs2.57 Billion Rs2.56 Billion Rs3.50 Billion Rs2.77 Billion Rs2.82 Billion
Total Current Liabilities Rs2.15 Billion Rs2.19 Billion Rs3.04 Billion Rs2.36 Billion Rs2.39 Billion
Long-term Debt — — — — Rs28.60 Million
Net Debt Rs-1.81 Billion Rs-2.35 Billion Rs-4.23 Billion Rs-3.17 Billion Rs-4.56 Billion
Total Stockholder Equity Rs5.37 Billion Rs5.38 Billion Rs7.51 Billion Rs6.16 Billion Rs7.04 Billion
Retained Earnings Rs5.09 Billion Rs1.58 Billion Rs3.71 Billion Rs2.37 Billion Rs3.28 Billion

Procter & Gamble Health Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Procter & Gamble Health Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20242023202220212020
Operating Cash Flow Rs1.76 Billion Rs2.28 Billion Rs2.36 Billion Rs1.70 Billion Rs2.47 Billion
Capital Expenditures Rs85.60 Million Rs217.30 Million Rs424.80 Million Rs379.20 Million Rs525.80 Million
Free Cash Flow Rs1.67 Billion Rs2.07 Billion Rs1.94 Billion Rs1.32 Billion Rs1.95 Billion
Investing Cash Flow Rs24.40 Million Rs-68.70 Million Rs-215.00 Million Rs-255.40 Million Rs-322.70 Million
Financing Cash Flow Rs-2.35 Billion Rs-4.18 Billion Rs-984.70 Million Rs-2.89 Billion Rs-3.87 Billion
Dividends Paid Rs-2.32 Billion Rs-4.15 Billion Rs937.90 Million Rs2.84 Billion Rs3.82 Billion
Stock-Based Compensation — Rs6.90 Million Rs5.60 Million Rs34.10 Million Rs19.30 Million
Depreciation Rs222.53 Million Rs274.00 Million Rs281.00 Million Rs270.80 Million Rs300.40 Million
Change in Cash Rs-2.52 Billion Rs-1.97 Billion Rs1.16 Billion Rs-1.45 Billion Rs-1.72 Billion

Procter & Gamble Health Limited Earnings History — EPS Actual vs. Analyst Estimates

Track Procter & Gamble Health Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 27, 2026 — — —
Feb 10, 2026 — — —
Aug 19, 2025 — — —
May 29, 2025 — — —
Feb 04, 2025 — — —
Nov 04, 2024 — — —
Nov 07, 2019 21.54 30.90 -30.29%
Aug 08, 2019 26.56 25.90 +2.55%